The Effects of Hydroalcoholic Extract from Alhagi on Matrix Metalloproteinase- 9 Production in Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis
-
Published:2020-08-21
Issue:4
Volume:10
Page:440-445
-
ISSN:2210-3155
-
Container-title:The Natural Products Journal
-
language:en
-
Short-container-title:NPJ
Author:
Ahmadi Mahbouba1, Ebrahimi Reyhane1, Ansari Mohammad1, Akhlaghi Masoumeh1, Mahmoudi Mahdi2, Amin Gholamreza3, Emamgholipour Solaleh1
Affiliation:
1. Biochemistry Department, Tehran University of Medical Sciences, Tehran, Iran 2. Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran 3. Pharmacognosy and Medicinal Plant Research Center Department, Tehran University of Medical Sciences, Tehran, Iran
Abstract
Background:
The up-regulation of matrix metalloproteinase 9 (MMP-9) along with the
imbalanced ratio of MMP-9 to tissue inhibitor of metalloproteinase 1 (TIMP-1) is important in the
pathogenesis of Rheumatoid Arthritis (RA). Here, we investigated whether hydroalcoholic extract
from the root of Alhagi camelorum Fisch can affect the levels of MMP-9 and TIMP-1 in peripheral
blood mononuclear cells (PBMCs) of RA patients.
Objective:
In the current study, we suggest that Alhagi may have an inhibitory effect on MMP-9
production, which is mainly responsible for joint destruction in RA. In addition, we would like to
stress that our findings, along with others, can provide the basis for future studies, which might help
in determining the role of chemical ingredients of Alhagi as therapeutic targets for RA treatment.
Methods:
PBMCs were isolated from 12 RA patients and 12 healthy subjects and treated with two
concentrations of Alhagi extract (100 and 500 μg/ml) for 24 h. MMP-9 gene expression and protein
production, TIMP-1 levels and nitric oxide (NO) production were evaluated using standard methods.
Results:
Alhagi (500 μg/ml) caused a significant reduction in the expression and activity of MMP-9
in PBMCs from healthy (p=0.003 for both of them) and patient (p= 0.05 and p=0.02 respectively)
subjects. Moreover, Alhagi (100 μg/ml) decreased MMP-9 production in the healthy subjects’ group
(p=0.02).
Conclusion:
The present study reveals the inhibitory effects of Alhagi on the production of MMP-9
as the main responsible cause of joint destruction in RA.
Funder
Tehran University of Medical Sciences
Publisher
Bentham Science Publishers Ltd.
Subject
Complementary and alternative medicine,Drug Discovery
Reference21 articles.
1. Asghari, M.H.; Fallah,M.; Moloudizargari,M.; Mehdikhani,F.; Sepehrnia,P.; Moradi, B. A systematic and mechanistic review on the phytopharmacological properties of Alhagi species. Anc. Sci. Life. 2016,36(2),65-71. http://dx.doi.org/10.4103/asl.ASL_37_16 PMID: 28446826 2. Batanouny,K.; Aboutabl,E.; Shabana,M.; Soliman F Wild Me-dicinal Plants in Egypt Swiss Development Co-operation (SDC) . Academy of Scientific Research and Technology, Egypt. The World Conservation Union; IUCN: Switzerland. 1999,102-104 3. Srivastava.; B. Alhagi pseudalhagi : A review of its phytochemistry, pharmacology, folklore claims and Ayurvedic studies. Int, J. Herbal Med. 2014,2(2),47-51 4. Nold,M.; Goede,A.; Eberhardt,W.; Pfeilschifter,J.; Mühl, H. IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: Suppression by TNF alpha blockage and modulation by IL-10. Naunyn Schmiedebergs Arch. Pharmacol. 2003,367(1),68-75. http://dx.doi.org/10.1007/s00210-002-0648-5 PMID: 12616343 5. Sarén,P.; Welgus, H.G.; Kovanen, P.T. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages, J. Immunol. 1996,157(9),4159-4165. PMID: 8892653
|
|